Psychedelic therapies gaining momentum as public perception of the drugs shift

Michael Mullette, MAPS Public Benefit Corp. COO, joins 'Fast Money' to discuss the growing psychedelic therapy market and how the drugs could follow cannabis' foot steps in legalization for medicinal and recreational use. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi